Induction and selection of Sox17-expressing endoderm cells generated from murine embryonic stem cells

Cells Tissues Organs. 2012;195(6):507-23. doi: 10.1159/000329864. Epub 2011 Nov 25.

Abstract

Embryonic stem (ES) cells offer a valuable source for generating insulin-producing cells. However, current differentiation protocols often result in heterogeneous cell populations of various developmental stages. Here we show the activin A-induced differentiation of mouse ES cells carrying a homologous dsRed-IRES-puromycin knock-in within the Sox17 locus into the endoderm lineage. Sox17-expressing cells were selected by fluorescence-assisted cell sorting (FACS) and characterized at the transcript and protein level. Treatment of ES cells with high concentrations of activin A for 10 days resulted in up to 19% Sox17-positive cells selected by FACS. Isolated Sox17-positive cells were characterized by defini- tive endoderm-specific Sox17/Cxcr4/Foxa2 transcripts, but lacked pluripotency-associated Oct4 mRNA and protein. The Sox17-expressing cells showed downregulation of extraembryonic endoderm (Sox7, Afp, Sdf1)-, mesoderm (Foxf1, Meox1)- and ectoderm (Pax6, NeuroD6)-specific transcripts. The presence of Hnf4α, Hes1 and Pdx1 mRNA demonstrated the expression of primitive gut/foregut cell-specific markers. Ngn3, Nkx6.1 and Nkx2.2 transcripts in Sox17-positive cells were determined as properties of pancreatic endocrine progenitors. Immunocytochemistry of activin A-induced Sox17-positive embryoid bodies revealed coexpression of Cxcr4 and Foxa2. Moreover, the histochemical demonstration of E-cadherin-, Cxcr4-, Sox9-, Hnf1β- and Ngn3-positive epithelial-like structures underlined the potential of Sox17-positive cells to further differentiate into the pancreatic lineage. By reducing the heterogeneity of the ES cell progeny, Sox17-expressing cells are a suitable model to evaluate the effects of growth and differentiation factors and of culture conditions to delineate the differentiation process for the generation of pancreatic cells in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activins / pharmacology
  • Animals
  • Biomarkers / metabolism
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Cell Lineage / drug effects
  • Cell Lineage / genetics
  • Cell Separation / methods*
  • Embryoid Bodies / cytology
  • Embryoid Bodies / drug effects
  • Embryoid Bodies / metabolism
  • Embryonic Stem Cells / cytology*
  • Embryonic Stem Cells / drug effects
  • Embryonic Stem Cells / metabolism*
  • Endoderm / cytology*
  • Endoderm / drug effects
  • Endoderm / metabolism*
  • Epithelium / drug effects
  • Epithelium / embryology
  • Epithelium / metabolism
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • Gene Expression Regulation, Developmental / drug effects
  • HMGB Proteins / metabolism*
  • Homeobox Protein Nkx-2.2
  • Luminescent Proteins / metabolism
  • Mice
  • Octamer Transcription Factor-3 / genetics
  • Octamer Transcription Factor-3 / metabolism
  • Pluripotent Stem Cells / cytology
  • Pluripotent Stem Cells / drug effects
  • Pluripotent Stem Cells / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • SOXF Transcription Factors / metabolism*
  • Time Factors

Substances

  • Biomarkers
  • HMGB Proteins
  • Homeobox Protein Nkx-2.2
  • Luminescent Proteins
  • Nkx2-2 protein, mouse
  • Octamer Transcription Factor-3
  • Pou5f1 protein, mouse
  • RNA, Messenger
  • SOXF Transcription Factors
  • Sox17 protein, mouse
  • activin A
  • fluorescent protein 583
  • Activins